Announced Tue, 30 Jun · 12:49 IST
Disclosure under SEBI Takeover Regulations submitted
Ownership Changes View source PDF
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+10.2%1-day move
₹204.41
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+10.2+8.0+5.9+3.8+1.7-1.9+14.3———
Up moveDown movePending
AI summary
Bafna Pharmaceuticals has submitted to the exchange a disclosure under Regulation 31(4) of SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. The specific nature of the disclosure (whether related to encumbrance, pledge, or stake change) is not detailed in the filing headline.
Likely market impact
Details awaited; the nature of the disclosure will clarify any impact on promoter holdings or encumbrances.